136 studies found for:    Carvedilol
Show Display Options
Rank Status Study
1 Completed A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding
Condition: Variceal Rebleeding
Interventions: Drug: carvedilol;   Drug: nadolol + ISMN
2 Completed Cocaine Withdrawal and Pharmacotherapy Response
Condition: Cocaine Addictions
Interventions: Drug: sugar pill;   Drug: carvedilol;   Drug: Methadone
3 Completed Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension
Condition: Hypertension
Interventions: Drug: Carvedilol SR 32mg, QD;   Drug: Carvedilol SR 64mg, QD;   Drug: Carvedilol IR 25mg, QD;   Drug: Carvedilol IR 25mg, BID
4 Unknown  Banding Ligation With Carvedilol Versus Carvedilol for the Prevention of First Bleeding
Condition: Variceal Bleeding
Interventions: Procedure: EVL + carvedilol;   Drug: carvedilol
5 Completed
Has Results
Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects
Condition: Healthy
Interventions: Drug: Carvedilol 25 mg tablets;   Drug: COREG® 25 mg tablets
6 Completed
Has Results
Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects
Condition: Healthy
Interventions: Drug: Carvedilol 25 mg tablets;   Drug: COREG® 25 mg tablets
7 Not yet recruiting Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
Conditions: Essential Hypertension;   Chronic Stable Angina;   Congestive Heart Failure
Interventions: Drug: Dilatrend SR capsule 32mg;   Drug: Dilatrend IR tablet 25mg
8 Completed A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure
Condition: Hypertension
Intervention: Drug: SK&F-105517 (COREG CR FDC)
9 Completed
Has Results
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
Condition: Congestive Heart Failure
Interventions: Drug: carvedilol controlled release;   Drug: carvedilol immediate release
10 Completed A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions
Condition: Healthy
Interventions: Drug: Carvedilol 12.5 mg Tablets, single dose;   Drug: Coreg® 12.5 mg Tablets , single dose
11 Completed Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
Conditions: Mood Disorder;   Substance-Related Disorders;   Amphetamine-Related Disorders
Interventions: Drug: 3,4-Methylenedioxymethamphetamine;   Drug: carvedilol;   Drug: placebo
12 Completed Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions
Condition: Healthy
Intervention: Drug: Carvedilol
13 Completed Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions
Condition: Healthy
Intervention: Drug: Carvedilol
14 Not yet recruiting Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Condition: Portal Hypertension Related to Cirrhosis
Interventions: Drug: Carvedilol;   Procedure: Variceal band ligation
15 Completed A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: Carvedilol 12.5 mg Tablets, single dose;   Drug: Coreg® 12.5 mg Tablets , single dose
16 Completed A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.
Condition: Hypertension
Interventions: Drug: COREG CR;   Drug: Lisinopril
17 Completed Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure
Condition: Congestive Heart Failure
Interventions: Drug: carvedilol;   Drug: placebo
18 Completed Danish Carvedilol Study in Portal Hypertension
Conditions: Cirrhosis;   Portal Hypertension
Interventions: Drug: carvedilol;   Drug: propranolol
19 Recruiting Trial of Carvedilol in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Carvedilol;   Drug: Placebo
20 Completed A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies
Condition: Insufficient Information
Interventions: Drug: Tab carvedilol 25 mg;   Drug: Tab carvedilol 6.25 mg;   Drug: Powder carvedilol up to 2.5 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years